NCT00204386View on ClinicalTrials.gov

Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

May 31, 2007

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Topiramate

Trial Locations (1)

73104

The University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

University of Oklahoma

OTHER

NCT00204386 - Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder | Biotech Hunter | Biotech Hunter